Abigail Fallas Mora

Dr. Abigail Fallas Mora

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2023 in Pharmacy
Verified
Journal Article
Open access
PDF file
AMAbigail Fallas Mora
Abigail Fallas Mora
JDJosé M Díaz-Madriz
José M Díaz-Madriz
Jose Miguel Chaverri-FernandezJose Miguel Chaverri-Fernandez
Jose Miguel Chaverri-Fernandez
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Background: Invasive fungal infections significantly contribute to mortality and morbidity rates. Despite the presence of all four major classes of antifungal medications, it is estimated that these infections result in the death of 1.5 million people each year, and death rates are increasing at an alarming rate. With increasing concerns about the emergence of antifungal resistance, there is a growing consideration in many countries to incorporate antifungal stewardship into existing antimicrobial stewardship programs. This approach aims to address issues hindering the appropriate use of antifungal drugs and to optimize their utilization. Methods: An analytical retrospective study of 48 hospitalized patients was conducted to assess factors related to the use of systemic antifungals and develop and implement an internal protocol to improve its use. Results: All patients with severe comorbidity had SOFA scores linked with a mortality risk of more than 10%. Based on 48 evaluations of antifungal orders, 62.5% were considered appropriate, 14.6% were considered debatable, and 22.9% were considered inappropriate. Infectious disease physicians made most of the prescriptions considered appropriate in this study. Conclusions: Comorbidities and risk factors in patients receiving systemic antifungals can be associated with the development of more serious fungal infections; hence, the implementation of antifungal stewardship as a complement to antimicrobial stewardship programs can help facilitate decision-making when dealing with a suspected case of fungal infection.

25 February 2023 in Hearts
Verified
Journal Article
Open access
PDF file
MSMario Osvaldo Speranza-Sánchez
Mario Osvaldo Speranza-Sánchez
JDJosé M Díaz-Madriz
José M Díaz-Madriz
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Jose Miguel Chaverri-FernandezJose Miguel Chaverri-Fernandez
Jose Miguel Chaverri-Fernandez
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
LVLuis Daniel Velásquez-Alfaro
Luis Daniel Velásquez-Alfaro
Heart failure (HF) is a syndrome suffered by more than 26 million people worldwide. SGLT2 inhibitors are drugs that have been shown to positively affect the management of HF patients, regardless of their diabetes status. A retrospective observational study was conducted on heart failure patients with reduced ejection fraction (HFrEF) enrolled at the HF clinic, who were on SGLT2 inhibitors. For these patients, baseline and follow-up data were collected and analyzed over time. Changes over time were quantified and statistical analysis was conducted to validate whether the changes were significant. After the screening of all the HF program patients, 24 met the inclusion criteria, with an average age of 68 years. Through the study, it was possible to find a statistically significant difference in the values of NT-ProBNP before and after adding a SGLT2 inhibitor in 14 patients (p = 0.0214). In addition, there was an improvement in the NYHA functional scale of 71% and no significant change in renal function or other laboratory values. Based on the studied parameters and throughout the clinical changes during the follow-up period, it was possible to establish an improvement in HFrEF patients on SGLT2 inhibitors as part of their therapy.

6 February 2026 in Revista Médica de la Universidad de Costa Rica
Verified
Journal Article
Open access
JBJosué Brenes-Camacho
Josué Brenes-Camacho
AMAbigail Fallas Mora
Abigail Fallas Mora
VRViviana Ramos-Rodríguez
Viviana Ramos-Rodríguez
MSMarietta Somarribas
Marietta Somarribas
NANavilla Apú
Navilla Apú
Between 2014 and 2024, the Centro Nacional de Control de Intoxicaciones (CNCI) in Costa Rica recorded 11,907 cases of pesticide poisoning, with 20 fatal outcomes (1). This issue is particularly serious in regions outside the Greater Metropolitan Area (GAM), where access to specialized services is limited. The objective of the study was to determine the main challenges in the management of pesticide poisoning in healthcare centers outside the GAM, based on the identification of the most commonly involved pesticides. A quantitative, cross-sectional, and retrospective study was conducted through the analysis of CNCI records, the application of questionnaires to healthcare professionals in the cantons with the highest incidence, and a review of scientific literature. The main pesticides involved were identified (pyrethroids, organophosphates, and unspecified substances), as well as the cantons with the highest number of reports (San Carlos, Pérez Zeledón, and Pococí). Additionally, challenges such as lack of medical training and limited access to supplies were identified

10 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SRSergio Restrepo-Arango
Sergio Restrepo-Arango
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
DQDiego Quesada-Loría
Diego Quesada-Loría
AMAbigail Fallas Mora
Abigail Fallas Mora
JGJonathan Garcia
Jonathan Garcia
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
Patient experience is key to patient-centered care and overall healthcare quality. This focus aligns with the growing trend of collaborative care, where patients actively participate in deci-sions alongside providers, leading to better outcomes. Patient experience goes beyond clinical results; it encompasses how patients feel throughout the care journey. Integrating patient per-spectives is essential for high-quality care. The study employed a multicenter, cross-sectional survey design utilizing a questionnaire-based approach. The data collection spanned two loca-tions within the Hospital Clínica Bíblica: San José, and Santa Ana, Costa Rica. The survey target-ed patients receiving treatment across the emergency department, surgery service, and inpatient department. A standardized Picker Patient Experience Questionnaire-33 (PPE-33) was adminis-tered to assess patients' overall experience with received services. A total of 390 questionnaires were analyzed. The participant demographics were as follows: 61.79% female, 56.15% aged be-tween 18 and 44, and 55.67% with undergraduate education. The hospital delivered high-quality service, with strong communication and accessibility (93.7%, 92.6%, and 94.4% positive respec-tively). Improvements are needed in patient rights education (22.7% positive), information about the patient's condition (74.3% positive), discharge instructions (36.5% and 71.4% positive for side effects and warning signs respectively) and addressing patient concerns (26.3% to 44.0%). Patients appreciated their privacy (95.2%), effective pain management (96.2%), respectful com-munication (97.0% and 94.8%), and overall respectful treatment. Satisfaction was influenced by factors like patient needs prioritization, rights communication, sociodemographic, health status, and comfort. The ward of admission had no significant impact on the experience. Enhancing pa-tient experience could boost loyalty and healthcare quality.

20 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAbigail Fallas Mora
Abigail Fallas Mora
KCKevin Cruz-Mora
Kevin Cruz-Mora
JMJeaustin Arón Mora
Jeaustin Arón Mora
Jose Miguel Chaverri-FernandezJose Miguel Chaverri-Fernandez
Jose Miguel Chaverri-Fernandez
JDJosé M Díaz-Madriz
José M Díaz-Madriz
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Background/Objectives:In-hospital cardiac arrest (IHCA) remains a critical event with high mortality, requiring coordinated multidisciplinary response. Return of spontaneous circulation (ROSC) and hospital discharge rates are key quality indicators in resuscitation efforts. In Latin America, there is limited data on team performance, protocol adherence, and the pharmacist’s role in code blue events. This study aimed to evaluate clinical outcomes and operational performance of code blue events at a Latin American hospital.Methods:This retrospective cohort study included 77 adult patients who experienced IHCA at Hospital Clínica Bíblica between 2020 and 2024. Data collection was conducted between February and May 2025 from electronic medical records and code blue activation logs. Clinical variables, comorbidities, pharmacologic interventions, and outcomes were analyzed. Predictive models (Charlson Comorbidity Index [CCI], IHCA-ROSC, RISQ-PATH) and Kaplan–Meier survival analysis were applied.Results: ROSC was achieved in 55.8% of patients, and 21% were discharged alive. Asystole was the predominant initial rhythm (76.6%), and comorbidities such as renal disease and myocardial infarction were most frequent. A higher comorbidity burden was significantly associated with lower discharge rates (p = 0.032). Despite 98.7% of patients being classified as low probability for ROSC by the IHCA-ROSC model, observed outcomes exceeded expectations (predicted: 5.53% vs. actual: 55.84%; p < 0.000001). The code team adhered to institutional protocols in 100% of cases, with clinical pharmacists playing a key role in documentation and medication tracking.Conclusions:Structured multidisciplinary response was associated with ROSC rates notably higher than predicted by validated models. Opportunities for improvement include post-event laboratory testing, pharmacist-led documentation, and therapeutic hypothermia in shockable rhythms.

31 March 2026 in Journal of Patient Experience
Verified
Journal Article
Open access
GHGeorgia Hanley-Vargas
Georgia Hanley-Vargas
AAAdriana Anchía-Alfaro
Adriana Anchía-Alfaro
DQDiego Quesada-Loría
Diego Quesada-Loría
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
AMAbigail Fallas Mora
Abigail Fallas Mora
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
This study evaluated patient experience in a private hospital in Costa Rica using the Picker Patient Experience Questionnaire-33 (PPE-33). A digital survey administered via Qualtrics ® targeted patients treated in emergency, surgical, or inpatient units between November 2024 and February 2025. A total of 567 valid responses were analyzed, exceeding the required sample size. The mean PPE-33 score indicated a satisfaction rate of 67.6%. The lowest-rated dimension was Patient Rights (27.9%), with few patients reporting being informed about their rights. In comparison, higher scores were observed for patient information (90.4%) and for confidentiality, privacy, pain management, and care (82.0%). Statistically significant differences were observed only by occupational status ( p =  .0122), with no variation by sex, age, educational level, or marital status. The emergency department consistently showed the lowest ratings across several dimensions. Overall, the findings highlight strengths and persistent gaps in patient-centered care and support the use of digital surveys as a feasible tool for monitoring patient experience and guiding quality improvement efforts in similar private hospital settings.